2013
DOI: 10.3109/02688697.2013.798857 View full text |Buy / Rent full text
|
|

Abstract: We report the first case of primary central nervous system lymphoma (PCNSL) developing in a patient with rheumatoid arthritis (RA) undergoing low-dose methotrexate therapy (LD-MTX). The characteristic clinical management and course in our experience of the present case illustrate the important points about PCNSL in methotrexate-associated lymphoproliferative disorders (MTX-LPD). The number of cases of MTX-LPD in RA patients may increase in the future, since current treatment strategies for RA recommend startin… Show more

Help me understand this report

Search citation statements

Order By: Relevance
0
0
0
0
0
0
16
0

Publication Types

Select...

Relationship

0
0

Authors

Journals